drugset / Trial / NCT06655220
A Study in Healthy Men to Test Whether BI 1815368 Influences the Amount of Metformin in the Body
RandomizedCrossoverOpen-labelTreatment
Summary
The main objective of this trial is to investigate the effect on the exposure of metformin in plasma when administered as an oral multiple dose together with multiple oral doses of BI 1815368 (Test, T) as compared to when metformin is administered as an oral multiple dose alone (Reference, R).
Timeline
- Start
- 2024-11-08
- Primary completion
- 2024-12-08
- Completion
- 2025-01-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1815368 | Unknown | — | — |
| Subject | Metformin | Small molecule | — | — |
Indications
No indication recorded.